Wexford Capital’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.53M Buy
33,480
+32,818
+4,957% +$2.34M 0.37% 32
2025
Q4
$40.9K Buy
662
+71
+12% +$4.18K 0.01% 329
2025
Q3
$34.7K Sell
591
-5,709
-91% -$333K 0.01% 349
2025
Q2
$367K Buy
+6,300
New +$356K 0.1% 131
2022
Q4
Sell
-4,212
Closed -$351K 164
2022
Q3
$351K Sell
4,212
-12,402
-75% -$1.07M 0.11% 93
2022
Q2
$1.32K Sell
16,614
-53,830
-76% -$5.23M 0.08% 73
2022
Q1
$7.33K Buy
70,444
+6,249
+10% +$518K 0.37% 24
2021
Q4
$4.83K Buy
+64,195
New +$4.49M 0.2% 46
2021
Q1
Sell
-80,000
Closed -$3.85M 296
2020
Q4
$3.85M Buy
80,000
+60,000
+300% +$2.65M 0.6% 45
2020
Q3
$785K Buy
+20,000
New +$728K 0.21% 78
2019
Q2
Sell
-214,428
Closed -$11.3M 132
2019
Q1
$11.3M Sell
214,428
-224,598
-51% -$11.7M 0.94% 17
2018
Q4
$20.6M Buy
439,026
+287,308
+189% +$15M 1.76% 9
2018
Q3
$8.75M Buy
151,718
+76,227
+101% +$4.22M 0.56% 20
2018
Q2
$4.11M Buy
+75,491
New +$3.74M 0.26% 41

Other funds holding NTR

Wexford Capital's NTR Position: Q1 2026 in Review

Wexford Capital increased its Nutrien (NTR) stake by 4,957% in Q1 2026, buying an estimated $2.34M and bringing the position to 33,480 shares worth $2.53M. The position accounts for 0.37% of the portfolio, ranked #32.

Wexford Capital first reported a position in NTR in Q2 2018 and has held it in 14 quarters since. The position peaked at $20.6M in Q4 2018. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Wexford Capital held 33,480 shares of Nutrien worth $2.53M as of Q1 2026.
  • Wexford Capital bought 32,818 Nutrien shares in Q1 2026, an estimated $2.34M.
  • Nutrien made up 0.37% of Wexford Capital's portfolio in Q1 2026, its #32 holding.
  • Wexford Capital first reported a position in Nutrien in Q2 2018 and has held it in 14 quarters since.
  • Wexford Capital's Nutrien position peaked at $20.6M in Q4 2018.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Wexford Capital's 13F filing for Q1 2026, filed 15 May 2026.